TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 45 filers reported holding TG THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,976,000 | +10.9% | 119,079 | +3.4% | 0.00% | 0.0% |
| Q1 2015 | $1,782,000 | -26.9% | 115,121 | -25.6% | 0.00% | -25.0% |
| Q4 2014 | $2,438,000 | +198.4% | 154,690 | +102.1% | 0.00% | +300.0% |
| Q3 2014 | $817,000 | +1845.2% | 76,558 | +989.8% | 0.00% | – |
| Q3 2013 | $42,000 | -4.5% | 7,025 | +1.0% | 0.00% | – |
| Q2 2013 | $44,000 | – | 6,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |